Education
About Us
Working with TipRanks
Follow Us
P3 Health Partners (PIII)
NASDAQ:PIII
PIII Stock Chart & Stats
Day’s Range― - ―
52-Week Range$6.50 - $33.70
Previous CloseN/A
Volume132.39K
Average Volume (3M)8.13K
Market Cap
$48.80M
Enterprise Value$59.76M
Total Cash (Recent Filing)$40.08M
Total Debt (Recent Filing)$75.98M
Price to Earnings (P/E)―
Beta1.19
Next Earnings
Aug 12, 2025EPS Estimate
-5.86Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-6.28
Shares Outstanding3,268,093
10 Day Avg. Volume4,879
30 Day Avg. Volume8,132
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.38
Price to Sales (P/S)0.00
P/FCF Ratio-0.19
Enterprise Value/Market Cap1.22
Enterprise Value/Revenue0.01
Enterprise Value/Gross Profit-2.72
Enterprise Value/Ebitda-0.10
Forecast
1Y Price Target
$14.00Price Target Upside115.38% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering4
P3 Health Partners News
PremiumCompany Announcements
P3 Health Partners Secures $70M Financing Deal
PremiumCompany Announcements
P3 Health Partners’ Earnings Call: Strategic Gains Amid Challenges
PremiumCompany Announcements
P3 Health Partners Reports Q1 2025 Financial Results
Bulls Say, Bears Say
Bulls Say
Operational ImprovementsPIII is ahead of schedule with respect to the previously announced ~$130M of adjusted EBITDA improvements.
Profit OutlookInitiatives the management team is implementing, especially with its stronger focus on exiting unprofitable markets and reworking risk-based contracts, lead to a more favorable profit outlook and lower cash burn.
ValuationThe analyst reiterates an Outperform rating and continues to believe P3 shares are undervalued at approximately 0.1 times 2026 sales.
Bears Say
Cash PositionThere is worry about PIII's tight cash position and the company's persistent struggle to improve earnings.
Earnings PerformanceResults this quarter were again disappointing, evidenced by a significant miss in adjusted EBITDA, and medical expenses remain a headwind.
Utilization And Costs VisibilityVisibility into utilization and costs is low, and PIII has missed consensus estimates for EBITDA in all of the last 7 quarters.
Options Prices
Currently, No data available
---
Ownership Overview
60.09% Insiders
1.83% Mutual Funds
8.73% Other Institutional Investors
28.19% Public Companies and
Individual Investors
PIII FAQ
What was P3 Health Partners’s price range in the past 12 months?
P3 Health Partners lowest stock price was $6.50 and its highest was $33.70 in the past 12 months.
What is P3 Health Partners’s market cap?
P3 Health Partners’s market cap is $48.80M.
When is P3 Health Partners’s upcoming earnings report date?
P3 Health Partners’s upcoming earnings report date is Aug 12, 2025 which is in 67 days.
How were P3 Health Partners’s earnings last quarter?
P3 Health Partners released its earnings results on May 15, 2025. The company reported -$6.28 earnings per share for the quarter, beating the consensus estimate of -$8.163 by $1.883.
Is P3 Health Partners overvalued?
According to Wall Street analysts P3 Health Partners’s price is currently Undervalued.
Does P3 Health Partners pay dividends?
P3 Health Partners does not currently pay dividends.
What is P3 Health Partners’s EPS estimate?
P3 Health Partners’s EPS estimate is -5.86.
How many shares outstanding does P3 Health Partners have?
P3 Health Partners has 3,268,093 shares outstanding.
What happened to P3 Health Partners’s price movement after its last earnings report?
P3 Health Partners reported an EPS of -$6.28 in its last earnings report, beating expectations of -$8.163. Following the earnings report the stock price went down -3.735%.
Which hedge fund is a major shareholder of P3 Health Partners?
Currently, no hedge funds are holding shares in PIII
P3 Health Partners Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$14.00 (115.38% Upside)
$14.00 (115.38% Upside)
Blogger Sentiment
Bullish
PIII Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 6.0 Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-75.00%
12-Months-Change
Fundamentals
Return on Equity
-131.17%
Trailing 12-Months
Asset Growth
-8.42%
Trailing 12-Months
Company Description
P3 Health Partners
P3 Health Partners (PIII) is a healthcare provider that operates within the managed care sector. The company focuses on delivering value-based care, primarily through partnerships with healthcare providers to offer coordinated and patient-centered care services. P3 Health Partners aims to improve patient outcomes and reduce healthcare costs by emphasizing preventive care and chronic disease management.
PIII Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflects a positive trajectory for P3 Health Partners with significant improvements in strategic initiatives, clinical performance, and operational metrics. However, challenges remain with declining revenue and membership and the impact of one underperforming payer contract.Read More>PIII Stock 12 Month Forecast
Average Price Target
$14.00
▲(115.38%Upside)
Technical Analysis
Community Health
―
ModivCare
―
Oncology Institute, Inc.
―
InnovAge Holding
―
Airsculpt Technologies
―